Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D deficiency was observed in 49% participants, with hyperhomocysteinemia in 34%, dual-risk in 22%, and executive dysfunction in 38% participants.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted a single-center, prospective, cross-sectional study of inpatients aged ≥60 years with hypertension (November 2023: July 2024).

Source: Abstract.

Patients were ineligible if they had (i) acute stroke or TIA under evaluation or confirmed within the prior 30 days (neuroimaging/neurology note), (ii) current delirium by a standardized screen at the time of cognitive testing (3D-CAM on wards or CAM-ICU in monitored settings), (iii) deep/ongoing sedation [continuous sedative infusion or Richmond Agitation-Sedation Scale (RASS) ≤ −2], (iv) severe sensory/motor barriers precluding valid testing, or (v) inability to communicate in Mandarin/local dialect.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of serum 25-hydroxyvitamin D and homocysteine “double-risk” status with executive dysfunction in older adults with hypertension

Cross-sectional study · Frontiers in Nutrition · 2026

Original publication title

Association of serum 25-hydroxyvitamin D and homocysteine “double-risk” status with executive dysfunction in older adults with hypertension

Lili Tan; Linya Zhao; Hongyan Li; Yamin Zhao; Yinyin Chen

Copyright © 2026 Tan, Zhao, Li, Zhao and Chen.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In older hypertensive inpatients, lower 25(OH)D and higher homocysteine are non-linearly associated with executive dysfunction, and co-occurrence confers excess risk beyond individual effects. Assessing both biomarkers may enhance risk stratification and guide trials of combined correction.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Executive dysfunction is common in adults with hypertension and undermines self-management. Low 25-hydroxyvitamin D [25(OH)D] and elevated homocysteine may damage the endothelium and white matter, while their non-linear dose: response and joint effects on executive dysfunction are unclear.

Source: Background

Abstract: What methods does the paper describe?

We conducted a single-center, prospective, cross-sectional study of inpatients aged ≥60 years with hypertension (November 2023: July 2024). Exposures were vitamin D deficiency [25(OH)D < 20 ng/mL] and hyperhomocysteinemia (hymocysteine ≥15 μmol/L), combined into a four-level dual-risk variable. Executive function was a composite of four tests. Non-linear associations were estimated with logistic regression using restricted cubic splines. Multiplicative interaction was assessed after adjustment for demographic, clinical, renal, lifestyle, supplementation, and seasonal covariates.

Source: Methods

Abstract: Results

Out of 498 individuals screened, 452 participants were analyzed. Vitamin D deficiency was observed in 49% participants, with hyperhomocysteinemia in 34%, dual-risk in 22%, and executive dysfunction in 38% participants. Non-linear associations were evident for both biomarkers (p_non-linear ≤0.04). Adjusted odds of executive dysfunction were 1.61 (95% CI 1.2 to 2.2) at 25(OH)D = 15 vs. 30 ng/mL and 1.4 (1.1 to 2.0) at homocysteine 18 vs. 10 μmol/L. Relative to neither risk, dual-risk had OR 2.1 (1.5 to 2.9) with multiplicative interaction (p = 0.03) and additive synergy (excess risk due to interaction 0.45, 95% CI 0.06 to 0.95).

Source: Results

Abstract: Conclusion

In older hypertensive inpatients, lower 25(OH)D and higher homocysteine are non-linearly associated with executive dysfunction, and co-occurrence confers excess risk beyond individual effects. Assessing both biomarkers may enhance risk stratification and guide trials of combined correction.

Source: Conclusion
Authors’ abstract

Background

Executive dysfunction is common in adults with hypertension and undermines self-management. Low 25-hydroxyvitamin D [25(OH)D] and elevated homocysteine may damage the endothelium and white matter, while their non-linear dose: response and joint effects on executive dysfunction are unclear.

Methods

We conducted a single-center, prospective, cross-sectional study of inpatients aged ≥60 years with hypertension (November 2023: July 2024). Exposures were vitamin D deficiency [25(OH)D < 20 ng/mL] and hyperhomocysteinemia (hymocysteine ≥15 μmol/L), combined into a four-level dual-risk variable. Executive function was a composite of four tests. Non-linear associations were estimated with logistic regression using restricted cubic splines. Multiplicative interaction was assessed after adjustment for demographic, clinical, renal, lifestyle, supplementation, and seasonal covariates.

Results

Out of 498 individuals screened, 452 participants were analyzed. Vitamin D deficiency was observed in 49% participants, with hyperhomocysteinemia in 34%, dual-risk in 22%, and executive dysfunction in 38% participants. Non-linear associations were evident for both biomarkers (p_non-linear ≤0.04). Adjusted odds of executive dysfunction were 1.61 (95% CI 1.2 to 2.2) at 25(OH)D = 15 vs. 30 ng/mL and 1.4 (1.1 to 2.0) at homocysteine 18 vs. 10 μmol/L. Relative to neither risk, dual-risk had OR 2.1 (1.5 to 2.9) with multiplicative interaction (p = 0.03) and additive synergy (excess risk due to interaction 0.45, 95% CI 0.06 to 0.95).

Conclusion

In older hypertensive inpatients, lower 25(OH)D and higher homocysteine are non-linearly associated with executive dysfunction, and co-occurrence confers excess risk beyond individual effects. Assessing both biomarkers may enhance risk stratification and guide trials of combined correction.

Publication and source details

Original title: Association of serum 25-hydroxyvitamin D and homocysteine “double-risk” status with executive dysfunction in older adults with hypertension

Lili Tan; Linya Zhao; Hongyan Li; Yamin Zhao; Yinyin Chen

Frontiers in Nutrition · 2026

* Correspondence: Yamin Zhao, hongye8013700@163.com; Yinyin Chen, Chenyinyin0219@163.com
†

These authors have contributed equally to this work

Copyright © 2026 Tan, Zhao, Li, Zhao and Chen.2026Tan, Zhao, Li, Zhao and Chenhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was supported by the Baoding Science and Technology Bureau (No. 2341ZF342).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:21:31.354853+00:00

DOI: 10.3389/fnut.2025.1718923 · PMC12855134